Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ElectromedAdvanced OncotherapyCyclopharmKromek GroupMRI Interventions
Price Information
Current Price$10.35GBX 26N/AGBX 12.40$3.19
52 Week RangeBuyBuyN/AN/AN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/AN/A
Consensus Price Target$12.00GBX 155N/AN/AN/A
% Upside from Price Target15.94% upside496.15% upsideN/AN/AN/A
Trade Information
Market Cap$87.75 million£63.55 million$95.49 million£42.73 million$48.51 million
Average Volume97,56579,755N/A290,23863,036
Sales & Book Value
Annual RevenueN/AN/A$17.01 million£16.17 millionN/A
Price / SalesN/AN/A0.002.64N/A
CashflowN/AGBX 1.67 per shareN/AGBX 3.90 per shareN/A
Price / CashN/A15.5616.003.18N/A
Book ValueN/AGBX 20 per shareA$0.30 per shareGBX 17.10 per shareN/A
Price / BookN/AN/A0.000.01N/A
Net IncomeN/AN/AN/AN/AN/A
EPSN/AGBX (14)A($0.04)GBX (0.40)N/A
Trailing P/E Ratio0.00N/AN/AN/A0.00
Forward P/E RatioN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutN/AN/AA$0.01N/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A55.71%21.21%16.69%N/A
Current RatioN/A2.16%5.64%4.20%N/A
Quick RatioN/A0.79%4.85%3.76%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding8.48 million244.42 million78.24 million344.56 million15.21 million
Next Earnings Date5/5/2020 (Estimated)N/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel